Semba J
Division of Health Sciences, University of the Air, Chiba, Japan.
Nihon Yakurigaku Zasshi. 2000 Aug;116(2):79-84. doi: 10.1254/fpj.116.79.
SSRIs have had a great impact on the diagnosis and treatment of depression, as well as the search for its pathophysiology. Since SSRIs have relatively few adverse effects, it is also effective for treating in a mild forms of depression, which were formerly thought to be treated adequately with only psychotherapy or anti-anxietics. Recent studies on the natural history of depression have revealed the chronicity of this disease. SSRI is now the first-line drug for the continuation and maintenance therapy of depression. Since SSRI primary acts on the serotonergic system, wide use of this drug has questioned the postulated dichotomy of the biological hypothesis of depression, the so-called serotonin depression or norepinephrine depression. A new insight into the monoamine hypothesis of depression has been yielded by SSRI. SSRIs are also effective in the treatment of anxiety disorders such as obsessive-compulsive disorder, panic disorder and social phobia. Thus, SSRIs have also brought new insight into the role of serotonin in the pathophysiology of anxiety.
选择性5-羟色胺再摄取抑制剂(SSRIs)对抑郁症的诊断、治疗及其病理生理学研究产生了重大影响。由于SSRIs的不良反应相对较少,它对轻度抑郁症也有效,而轻度抑郁症以前被认为仅通过心理治疗或抗焦虑药就能得到充分治疗。最近关于抑郁症自然病程的研究揭示了这种疾病的慢性特征。SSRI现在是抑郁症持续治疗和维持治疗的一线药物。由于SSRI主要作用于5-羟色胺能系统,这种药物的广泛使用对抑郁症生物学假说中假定的二分法提出了质疑,即所谓的5-羟色胺抑郁症或去甲肾上腺素抑郁症。SSRI为抑郁症单胺假说带来了新的见解。SSRIs在治疗强迫症、恐慌症和社交恐惧症等焦虑症方面也有效。因此,SSRIs也为5-羟色胺在焦虑症病理生理学中的作用带来了新的见解。